Skip to main navigation Skip to search Skip to main content

A phase 4 randomized clinical trial of andexanet alfa (andexanet alfa for injection) in acute intracranial hemorrage in patients receiving an oral factor Xa inhibitor

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date08/3/21 → 08/2/24

Funding

  • Portola Pharmaceuticals: $40,805.00